IPO Timeline
Broker Results (T-2)
2021-07-13
Some brokers release in afternoon
Grey Market (T-1)
2021-07-14
Afternoon
HKEX Allotment (T-1)
2021-07-14
Evening
Registrar Allotment (T-1)
2021-07-14
Evening
Listing Day (T)
2021-07-15
First day of trading
Company Overview
| Stock Name | 醫脈通科技有限公司 |
| Stock Code | 02192 |
| Company Full Name | 醫脈通科技有限公司 |
| Industry | 軟件服務 |
| Principal Activities | 主要在中國提供數字醫療營銷服務及臨床研究服務、數字醫學信息服務及數字慢性疾病管理服務。 |
| Listing Date | 2021-07-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市朝陽區朝陽北路白家樓甲1號紅莊國際文化保稅創新園 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.medlive.cn |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism |
To be extracted
|
| Offer Price | HK$ 27.20 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 40.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 2,109,305,600 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 31.0 |
| First Day Open | HK$ 28.9 |
| First Day Change | 13.97% |
| First Day Volume | 115437000.0 |
| First Day Turnover | 3544610000.0 |
Use of Proceeds
| Use of Proceeds | 1、約40%(約1,600.4百萬港元)擬用于在未來三至五年內擴展業務;
2、約30%(約1,200.3百萬港元)擬用于在未來三至五年內投資技術及提高研發能力;
3、約20%(約800.2百萬港元)擬用于有精心挑選戰略投資或收購機會;
4、約10%(約400.1百萬港元)擬用作一般補充營運資金及其他一般企業用途。 |
Underwriting Syndicate
Joint Sponsors (2)
高盛(亚洲)有限责任公司 CE ACC536
海通国际资本有限公司 CE ADQ859
Overall Coordinators (3)
高盛(亚洲)有限责任公司 CE ACC536
海通国际证券有限公司 CE AAF806
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (3)
高盛(亚洲)有限责任公司 CE ACC536
海通国际证券有限公司 CE AAF806
中国国际金融香港证券有限公司 CE AEN894
Joint Lead Managers (3)
高盛(亚洲)有限责任公司 CE ACC536
海通国际证券有限公司 CE AAF806
中国国际金融香港证券有限公司 CE AEN894
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
Fidelity International |
310,501,600 HKD |
— |
7.36% |
— |
6 months |
2022-01-15 |
| 2 |
Fidelity Management & Research (Hong Kong) Limited |
310,501,600 HKD |
— |
7.36% |
— |
6 months |
2022-01-15 |
| 3 |
GIC Private Limited |
310,501,600 HKD |
— |
7.36% |
— |
6 months |
2022-01-15 |
| 4 |
Matthews Asia Funds |
155,244,000 HKD |
— |
3.68% |
— |
6 months |
2022-01-15 |
| 5 |
OrbiMed Funds |
155,244,000 HKD |
— |
3.68% |
— |
6 months |
2022-01-15 |
| 6 |
Springhill Master Fund Limited |
155,244,000 HKD |
— |
3.68% |
— |
6 months |
2022-01-15 |
| 7 |
Tencent Mobility Limited |
310,501,600 HKD |
— |
7.36% |
— |
6 months |
2022-01-15 |
Directors & Management
| Chairman | 田立平 |
| Company Secretary | 楊艷玲 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | M3, Inc.(37.48%);田立平及家族成員(37.48%);FIL Limited(7.98%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.